Publications by authors named "Ray Moseley"

Article Synopsis
  • The algorithmic patient preference predictor (PPP) aims to help make decisions for incapacitated patients when there are no advanced directives, highlighting both ethical challenges and practical issues in personalizing predictions.
  • A review of studies found 68 using machine learning to predict patient-reported outcome measures (PROMs), with orthopedic and spinal surgeries being the most common focus; however, overall predictive performance was generally poor to moderate.
  • Pre-event PROMs emerged as key predictors of post-event outcomes, indicating the need to integrate patient preferences into developing personalized PPP models, which currently lack adequate fairness assessments.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of large language models (LLMs) in incorporating patient values during critical medical decision-making for patients who can't make decisions due to incapacitation.
  • Researchers simulated scenarios for 50 patients needing urgent medical decisions and assessed how well LLMs could extract treatment options and provide recommendations based on the patients' values.
  • Results showed that LLMs accurately extracted treatment information 88% of the time and received good scores for their recommendations in terms of medical plausibility and alignment with patient values, especially when values were expressed in free-text narratives.
View Article and Find Full Text PDF

Background: Advance directives are legal documents that include living wills and durable health care power of attorney documents. They are critical components of care for seriously ill patients which are designed to be implemented when a patient is terminally ill and incapacitated. We sought to evaluate potential reasons for why advance directives were not appropriately implemented, by reviewing the electronic health record (EHR) in patients with terminal cancer.

View Article and Find Full Text PDF

Purpose: Patients are frequently asked to share their personal health information. The objective of this study was to compare the effects on patient experiences of 3 electronic consent (e-consent) versions asking patients to share their health records for research.

Methods: A multi-arm randomized controlled trial was conducted from November 2017 through November 2018.

View Article and Find Full Text PDF

Objective: In the context of patient broad consent for future research uses of their identifiable health record data, we compare the effectiveness of interactive trust-enhanced e-consent, interactive-only e-consent, and standard e-consent (no interactivity, no trust enhancement).

Materials And Methods: A randomized trial was conducted involving adult participants making a scheduled primary care visit. Participants were randomized into 1 of the 3 e-consent conditions.

View Article and Find Full Text PDF

Objective: The purpose of this study was to assess patient perceptions of using an interactive electronic consent (e-consent) application when deciding whether or not to grant broad consent for research use of their identifiable electronic health record (EHR) information.

Materials And Methods: For this qualitative study, we conducted a series of 42 think-aloud interviews with 32 adults. Interview transcripts were coded and analyzed using a modified grounded theory approach.

View Article and Find Full Text PDF

Targeted testing programs are identifying increasing numbers of adults affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) who are making decisions about genetic testing for their at-risk children. Although there are possible benefits, there are also potential risks. The purpose of this pilot study was to explore attitudes toward testing at-risk children from the first hand perspective of those involved, identify the benefits and risks experienced therein, and compare the views of parents and adults tested as children (ATC).

View Article and Find Full Text PDF

Some of today's most significant bioethical challenges center around decisions to initiate or withhold medical treatment for incapacitated patients. In order to ascertain what treatment the patient would have desired, physicians often rely on written advance directives and designated surrogate decision-makers. Unfortunately, both approaches suffer from numerous shortcomings that ultimately limit their usefulness.

View Article and Find Full Text PDF

The Florida Panel for the Study of End-of-Life Care was an innovative and effective approach to the formulation of end-of-life (EOL) policy recommendations that significantly influenced the legislative process and resulted in new EOL legislation. The lessons from this panel's experience are useful to other states considering legislative changes in their EOL policies. Key to the success of the EOL panel was its heterogeneous membership that allowed the collaboration of policy makers, clinicians, ethicists, citizens, and other stakeholders.

View Article and Find Full Text PDF